Adjuvant recombinant human endostatin combined with toripalimab (anti-PD-1) in locally advanced melanoma: an exploratory phase 2 clinical trial incorporating single-cell RNA/TCR/BCR sequencing. - Hu X; Xu Y; Wang Z; Yang L; Zheng B; Sun F; Liu D; Shi B; Zheng H; Liu X; Yu L; Zhang S; et al. (Molecular cancer, 2026)